
Understanding Prophylaxis
Prophylaxis refers to the regular infusion of clotting factor concentrates to prevent bleeding episodes in individuals with haemophilia. The concept of prophylaxis arose from observations that individuals with moderate or mild haemophilia, characterized by clotting factor levels of 1% or more, rarely experience spontaneous bleeding and have less joint damage compared to those with severe haemophilia.
It's important to note that while prophylaxis cannot repair already damaged joints, it can significantly decrease the frequency of bleeding episodes and may slow the progression of joint disease. This can lead to improvements in quality of life for individuals with haemophilia. The goal of prophylaxis is to maintain minimum factor levels around 1% through regular infusions of clotting factor concentrates, thereby reducing the risk of bleeding and preventing further joint damage. Studies have demonstrated that children who receive prophylaxis experience fewer bleeds and have healthier joints compared to those who do not.
Today, prophylaxis is considered the standard of care in haemophilia treatment, allowing individuals to lead active lives and participate more fully in daily activities without the constant fear of bleeding episodes. By providing ongoing protection against bleeding, prophylaxis enables individuals with haemophilia to pursue their goals and enjoy a better quality of life.